Literature DB >> 6089353

Technetium-99m-labeled red blood cell imaging.

D Front, O Israel, D Groshar, J Weininger.   

Abstract

Red blood cells labeled with 99mTc constitute a suitable intravascular agent for imaging of vascular abnormalities. Hemangiomas are characterized by low perfusion and a high blood pool. This "perfusion blood-pool mismatch," not encountered in other lesions, may help in the specific diagnosis of this tumor. This is particularly so in cavernous hemangiomas of the liver where three-phase 99mTc-labeled red blood cell scintigraphy should precede liver biopsy. Red cell scintigraphy also is useful for establishing the vascular nature of hemangiomas of the head and neck and the skin and for diagnosis of venous occlusion. Heat-damaged red blood cells provide a specific spleen imaging agent. This should be used when patients with suspected splenic pathology have equivocal colloid scintigraphy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6089353     DOI: 10.1016/s0001-2998(84)80017-3

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  5 in total

1.  Pitfalls of a 99mTc-RBC bleeding study due to gallbladder and ileal-loop visualization.

Authors:  R Abello; T P Haynie; E E Kim
Journal:  Gastrointest Radiol       Date:  1991

2.  Technetium-99m-labelled red blood cell imaging in the diagnosis of hepatic haemangiomas: the role of SPECT/CT with a hybrid camera.

Authors:  Orazio Schillaci; Roberta Danieli; Carlo Manni; Francesca Capoccetti; Giovanni Simonetti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-31       Impact factor: 9.236

3.  Ferumoxytol-enhanced MR imaging for differentiating intrapancreatic splenules from other tumors.

Authors:  M R Muehler; V R Rendell; L L Bergmann; E R Winslow; S B Reeder
Journal:  Abdom Radiol (NY)       Date:  2020-12-30

4.  A case of intraorbital hemangioma diagnosed with tc 99m labeled erythrocyte scintigraphy and magnetic resonance imaging.

Authors:  Tansel Ansal Balcı; Zeyra Pınar Koc; Burak Turgut; Ayse Murat Aydın; Bedriye Busra Demirel
Journal:  Mol Imaging Radionucl Ther       Date:  2011-04-01

5.  Preclinical evaluation of carbon-11 and fluorine-18 sulfonamide derivatives for in vivo radiolabeling of erythrocytes.

Authors:  Olivier Gheysens; Vamsidhar Akurathi; Rufael Chekol; Tom Dresselaers; Sofie Celen; Michel Koole; Dieter Dauwe; Bernard J Cleynhens; Piet Claus; Stefan Janssens; Alfons M Verbruggen; Johan Nuyts; Uwe Himmelreich; Guy M Bormans
Journal:  EJNMMI Res       Date:  2013-01-15       Impact factor: 3.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.